INTRAFEN is the first and only Ibuprofen brand in I.V. preparation launched in the Philippines in August 2018. DPII is proud in initiating the availability of INTRAFEN, as it is recognized for its significance in treating severely ill patients. Study shows that Ibuprofen has been rated as the safest conventional Nonsteroidal anti-inflammatory drug (NSAID).
Delex Pharma acquires the product from Mefar, which is a leading pharmaceutical institution in Turkey. Moreover, it is among the reputable contract manufacturer of parenteral solutions for human and veterinary usage in ampoules, vials, BFS (blow-fill-seal), PFS (pre-filled syringes), and freeze-dried products.
INTRAFEN is available in selected Mercury Drug branches.
DISCLAIMER: The following contents are intended for healthcare professionals only. If you are a patient or general mass viewing this site, we advise you to clarify with your doctor any information you read herein.
|
Generic Name:
|
IBUPROFEN
|
|
Brand Name:
|
INTRAFEN
|
|
Sizes:
|
100 mG/mL (400 mg/ 4mL), (800 mG / 8mL)
|
|
Preparation:
|
100 mg/mL in 4 mL & 8 mL vials; Solution for Intravenous Infusion
|
|
Name of Manufacturer
|
Mefar Ilac Sanayii A.S.
|
|
Place of Manufacturer:
|
Turkey
|
|
Shelf Life
|
24 months
|
|
Storage Condition:
|
Store at temperature not exceeding 30 ͦC
|
|
Packaging:
|
4 mL in 6 mL-capacity USP Type I clear and colorless glass vial; 8 mL in 10 mL-capacity USP Type I clear and colorless glass vial
|
|
FDA Registration:
|
DR-XY46120 (4 mL); DR-XY46190 (8 mL)
|
